Various blood cancers, including acute lymphoblastic leukaemia and acute myeloid leukaemia (AML), also exhibit elevated MERTK expression [33, 34], with its expression crucial for tumour cells to evade innate immune surveillance. The gene discussed is MERTK; the disease is neoplasm.